Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is strikingly resistant to conventional therapeutic approaches. We previously demonstrated that the histone deacetylase-associated protein SIN3B is essential for oncogene-induced senescence in cultured cells. Here, using a mouse model of pancreatic cancer, we have demonstrated that SIN3B is required for activated KRAS-induced senescence in vivo. Surprisingly, impaired senescence as the result of genetic inactivation of Sin3B was associated with delayed PDAC progression and correlated with an impaired inflammatory response. In murine and human pancreatic cells and tissues, levels of SIN3B correlated with KRAS-induced production of IL-1α. Furthermore, evaluation of human pancreatic tissue and cancer cells revealed that Sin3B was decreased in control and PDAC samples, compared with samples from patients with pancreatic inflammation. These results indicate that senescence-associated inflammation positively correlates with PDAC progression and suggest that SIN3B has potential as a therapeutic target for inhibiting inflammation-driven tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to other malignancies, pancreatic cancer is highly resistance to chemotherapy and targeted therapy [3, 4].”
From Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma (2015) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Accordingly, senescenceassociated β-gal (SA–β-gal) positivity (44) was markedly reduced in Sin3B-deficient pancreata (Figure 3B).”
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 1×
“Through its ability to drive a potent cell-cycle exit, cellular senescence has long been considered a tumor-suppressive mechanism (9, 13, 14).”
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“In addition, a recent study indicated that disabling the IL-1R/IL-1α pathway partially prevents oncogene-induced senescence and paracrine senescence (50).”
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219 · cited 1×
“In agreement with our observations, a recent study indicated that the senescence secretome promotes liver cancer progression (21).”
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 1×
“Senescence is associated with low proliferation in a wide variety of cancer preneoplastic lesions, including lung adenoma, melanocytic naevi, and PanIN (8, 10–12).”
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 9×
“However, the molecular factors that link oncogene activation to SASP expression remain largely elusive.”
InfluentialFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 2×
“IL-1α has recently been shown to serve as an upstream regulator of SASP production (45).”
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · cited 2×
“Through its ability to drive a potent cell-cycle exit, cellular senescence has long been considered a tumor-suppressive mechanism (9, 13, 14).”
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898 · cited 1×
“We next investigated whether Sin3B inactivation affects the progression of KRasG12D-driven PanINs by crossing Sin3Bp–/– mice with Cre-inducible Lox-STOP-Lox-KRasG12D mice (37).”
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 1×
“SASP triggers senescence in neighboring cells and mobilizes immune cells, but can also induce inflammation and thus promote cancer progression (18, 42, 43).”
Genetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126 · cited 1×
“Molecular pathology studies of human specimens and the development of genetically engineered mouse models have demonstrated that PDAC arises from noninvasive precursor lesions known as pancreatic intraepithelial neoplasia (PanIN), which are driven by activating KRas mutations (1–5).”
Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes & Development · doi:10.1101/gad.1158703 · Cited by 1,033 · cited 1×
“Histologic examination of additional animals at different time points revealed PanIN surrounded by extensive fibrosis as early as 6 to 8 weeks and progressively higher grade lesions in Sin3Bp+/– KRaspG12D mice (Figure 1B), as previously reported (2).”
The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors
Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R. J., & Wright, C. V. E. (2002) · Nature Genetics · doi:10.1038/ng959 · Cited by 1,007 · cited 2×
“org Volume 124 Number 5 May 2014 tional allele were first crossed with transgenic mice expressing the Cre recombinase under the control of the pancreas-specific p48 promoter (35, 36).”
Senescence-messaging secretome: SMS-ing cellular stress
Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909
Wajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · cited 1×
“Recently, it was demonstrated that senescent cells secrete a specific set of proinflammatory cytokines, including ILs (such as IL-1 α , IL-1 β , IL-6, and IL-8), chemokines, and growth factors, known collectively as the senescence-associated secretory phenotype (SASP) (15–17).”
Histone Deacetylase Inhibitors in Cancer Therapy
Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 874
Lesina, M., Kurkowski, M. U., Ludes, K., Rose-John, S., Treiber, M., Klöppel, G., Yoshimura, A., Reindl, W., Sipos, B., Akira, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.009 · Cited by 862
Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia
Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G., & Bar-Sagi, D. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.024 · Cited by 721 · cited 1×
“Inflammation in evolving PanINs is associated with a positive feedback loop of cytokine secretion involving pancreatic cells, immune cells, and cancer-associated fibroblasts (CAF) (25, 26).”
Self-citationMutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Morton, J. P., Timpson, P., Karim, S. A., Ridgway, R. A., Athineos, D., Doyle, B., Jamieson, N. B., Oien, K. A., Lowy, A. M., Brunton, V. G., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908428107 · Cited by 657 · cited 2×
“These mutations promote cellular proliferation in the presence of an activated oncogene in vitro and are detected in high-grade PanIN lesions and PDAC in human specimens (2, 4, 6–8).”
Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., & Campisi, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905299106 · Cited by 654
Senescent cells as a source of inflammatory factors for tumor progression
Davalos, A. R., Coppe, J.-P., Campisi, J., & Desprez, P.-Y. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9220-9 · Cited by 636 · cited 2×
“SASP triggers senescence in neighboring cells and mobilizes immune cells, but can also induce inflammation and thus promote cancer progression (18, 42, 43).”
Bardeesy, N., Aguirre, A. J., Chu, G. C., Cheng, K.-H., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 581
Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
Fukuda, A., Wang, S. C., Morris, J. P., Folias, A. E., Liou, A., Kim, G. E., Akira, S., Boucher, K. M., Firpo, M. A., Mulvihill, S. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.002 · Cited by 521 · cited 1×
“This phenomenon is particularly relevant in pancreatic cancer, where inflammation is a well-established factor in tumor progression (23, 26).”
Guerra, C., Collado, M., Navas, C., Schuhmacher, A. J., Hernández-Porras, I., Cañamero, M., Rodriguez-Justo, M., Serrano, M., & Barbacid, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.011 · Cited by 516 · cited 1×
“To do so, we generated Sin3Bp+/– KRaspG12D Ink4a/ Arfflox/flox and Sin3Bp–/– KRaspG12D Ink4a/Arfflox/flox mice (hereafter referred to as Sin3Bp+/– KRaspG12DInk4ap–/– and Sin3Bp–/– KRaspG12D Ink4ap–/–), since deletion of the Ink4a/Arf locus results in the bypass of senescence (46, 47).”
Ling, J., Kang, Y., Zhao, R., Xia, Q., Lee, D.-F., Chang, Z., Li, J., Peng, B., Fleming, J. B., Wang, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.006 · Cited by 513 · cited 1×
“Finally, recent studies demonstrate a critical function for IL-1 α in the initiation of the proinflammatory phenotype in the pancreas (26, 28–30).”
STAT3 Plays a Critical Role in KRAS -Induced Pancreatic Tumorigenesis
Corcoran, R. B., Contino, G., Deshpande, V., Tzatsos, A., Conrad, C., Benes, C. H., Levy, D. E., Settleman, J., Engelman, J. A., & Bardeesy, N. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0908 · Cited by 413 · cited 1×
“This notion is particularly relevant to PDAC, as its progression is intimately linked to inflammation (1, 22–26).”
Habbe, N., Shi, G., Meguid, R. A., Fendrich, V., Esni, F., Chen, H., Feldmann, G., Stoffers, D. A., Konieczny, S. F., Leach, S. D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810097105 · Cited by 408
Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia
De La O, J.-P., Emerson, L. L., Goodman, J. L., Froebe, S. C., Illum, B. E., Curtis, A. B., & Murtaugh, L. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810111105 · Cited by 397 · cited 14×
“Interestingly, in most samples with high levels of SIN3B expression, we also observed p-STAT3 and IL-1 α positivity, specifically at the sites of ADM and in PanIN lesions (Figure 6A).”
InfluentialCellular senescence as a tumor-suppressor mechanism
Campisi, J. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)82148-6 · Cited by 390 · cited 1×
“Discussion Senescence has commonly been considered a tumor-suppressive mechanism (48).”
Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras
Friedlander, S. Y. G., Chu, G. C., Snyder, E. L., Girnius, N., Dibelius, G., Crowley, D., Vasile, E., DePinho, R. A., & Jacks, T. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.027 · Cited by 338 · cited 1×
“Recent lineage-tracing studies indicate that the majority of human and mouse PanIN lesions result from the transdifferentiation of acinar cells into ductal cells through a process known as acinar-to-ductal metaplasia (ADM) (38–40).”
Role of Immune Cells and Immune-Based Therapies in Pancreatitis and Pancreatic Ductal Adenocarcinoma
Zheng, L., Xue, J., Jaffee, E. M., & Habtezion, A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2012.12.042 · Cited by 323 · cited 1×
“Since repeated episodes of acute pancreatitis can progress to chronic pancreatitis, a wellknown risk factor for PDAC (56), mitigating the effects of acute pancreatitis may offer an approach for lowering the frequency of PDAC in the population.”
The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment
Li, N., Grivennikov, S. I., & Karin, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.018 · Cited by 245 · cited 2×
“The cellular factors that contribute to the oncogene-driven inflammation in pancreatic cells remain for the most part unknown, but recent studies have implicated IL-1 α expression as an inducer of constitutive NF-κ B activation and subsequent inflammation (27–30).”
Genetically engineered mouse models of pancreatic adenocarcinoma
Guerra, C., & Barbacid, M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.002 · Cited by 179
RPD1 (SIN3/UME4) is required for maximal activation and repression of diverse yeast genes.
Vidal, M., Strich, R., Esposito, R. E., & Gaber, R. F. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.12.6306 · Cited by 167 · cited 1×
“SIN3 proteins are noncatalytic scaffolding proteins that serve as evolutionarily conserved components of the histone deacetylase HDAC1/2 transcriptional repression complex (31, 32).”
Wang, H., Clark, I., Nicholson, P. R., Herskowitz, I., & Stillman, D. J. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5927 · Cited by 151
Klein, W. M., Hruban, R. H., Klein–Szanto, A. J., & Wilentz, R. E. (2002) · Modern Pathology · doi:10.1038/modpathol.3880544 · Cited by 134
Oncogenic KRas Suppresses Inflammation-Associated Senescence of Pancreatic Ductal Cells
Lee, K. E., & Bar-Sagi, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.020 · Cited by 131 · cited 1×
“To do so, we generated Sin3Bp+/– KRaspG12D Ink4a/ Arfflox/flox and Sin3Bp–/– KRaspG12D Ink4a/Arfflox/flox mice (hereafter referred to as Sin3Bp+/– KRaspG12DInk4ap–/– and Sin3Bp–/– KRaspG12D Ink4ap–/–), since deletion of the Ink4a/Arf locus results in the bypass of senescence (46, 47).”
Tjomsland, V., Spångeus, A., Välilä, J., Sandström, P., Borch, K., Druid, H., Falkmer, S., Falkmer, U., Messmer, D., & Larsson, M. (2011) · Neoplasia · doi:10.1593/neo.11332 · Cited by 122
David, G., Grandinetti, K. B., Finnerty, P. M., Simpson, N., Chu, G. C., & DePinho, R. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710285105 · Cited by 119 · cited 1×
“org Volume 124 Number 5 May 2014 tional allele were first crossed with transgenic mice expressing the Cre recombinase under the control of the pancreas-specific p48 promoter (35, 36).”
Self-citationSawey, E. T., Johnson, J. A., & Crawford, H. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705953104 · Cited by 113 · cited 1×
“To assess whether SIN3B regulates ADM in a cell-autonomous manner, acinar cells from 5 week-old Sin3Bp+/– KRaspG12D mice and their Sin3Bp–/– KRaspG12D littermates (Supplemental Figure 2A) were cultured using a 3D matrix (41).”
Niu, J., Li, Z., Peng, B., & Chiao, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309789200 · Cited by 102
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer
Caldwell, M. E., DeNicola, G. M., Martins, C. P., Jacobetz, M. A., Maitra, A., Hruban, R. H., & Tuveson, D. A. (2012) · Oncogene · doi:10.1038/onc.2011.350 · Cited by 97 · cited 13×
“Recent studies suggested that SA–β-gal positivity alone cannot be used to definitely specify senescent cells in the pancreas (11).”
InfluentialMelisi, D., Niu, J., Chang, Z., Xia, Q., Peng, B., Ishiyama, S., Evans, D. B., & Chiao, P. J. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0201 · Cited by 92 · cited 2×
“Finally, recent studies demonstrate a critical function for IL-1 α in the initiation of the proinflammatory phenotype in the pancreas (26, 28–30).”
Agbunag, C., & Bar-Sagi, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0807 · Cited by 85
Jelinic, P., Pellegrino, J., & David, G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00840-10 · Cited by 80 · cited 1×
“An alternative explanation for this positive regulation of IL-1α by SIN3B may stem from our recent observation that SIN3B participates in the release of polymerase pausing at active promoters, thus modulating the levels of actively transcribed genes (51).”
Self-citationRas-Induced Senescence and its Physiological Relevance in Cancer
DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 76 · cited 1×
“Through its ability to drive a potent cell-cycle exit, cellular senescence has long been considered a tumor-suppressive mechanism (9, 13, 14).”
Self-citationSin3B Expression Is Required for Cellular Senescence and Is Up-regulated upon Oncogenic Stress
Grandinetti, K. B., Jelinic, P., DiMauro, T., Pellegrino, J., Fernández Rodríguez, R., Finnerty, P. M., Ruoff, R., Bardeesy, N., Logan, S. K., & David, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0537 · Cited by 54 · cited 6×
“Based on our recent discovery that SIN3B is required for oncogene-induced senescence in mouse embryonic fibroblasts (34), we investigated whether Sin3B deletion affects the senescence process in pancreatic lesions.”
InfluentialSelf-citationCurrent evidence for histone deacetylase inhibitors in pancreatic cancer
Koutsounas, I. S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i6.813 · Cited by 47 · cited 1×
“Accordingly, HDAC inhibitors are currently being tested in association with radiotherapy or chemotherapy in phase I and phase II clinical trials in patients with local, advanced, and metastatic disease (52–54).”
Agbunag, C., Lee, K. E., Buontempo, S., & Bar‐Sagi, D. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07055-2 · Cited by 44 · cited 2×
“Primary acinar cell cultures were prepared by modifying published protocols (41, 57, 58).”
Cytokine Expression and Induction of Acinar Cell Apoptosis after Pancreatic Duct Ligation in Mice
Yasuda, H., Kataoka, K., Ichimura, H., Mitsuyoshi, M., Iida, T., Kita, M., & Imanishi, J. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313785 · Cited by 37 · cited 1×
“Furthermore, IL-1α is a central cytokine expressed after acute pancreatitis (55) and preliminary data in our laboratory show that IL-1α positively correlates with ADM maintenance in a mouse pancreatitis model (M.”
Tinari, N., Tursi, M. D., Grassadonia, A., Zilli, M., Stuppia, L., Iacobelli, S., & Natoli, C. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912800190884 · Cited by 35
Grandinetti, K. B., & David, G. (2008) · Cell Cycle · doi:10.4161/cc.7.11.6052 · Cited by 31 · cited 1×
“We have recently demonstrated that mouse embryonic fibroblasts genetically inactivated for Sin3B are refractory to quiescence as well as oncogene-induced senescence (33–35).”
Self-citation
Research works printed but not linked: 1
- Acosta JC, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978–990. doi: 10.1038/ncb2784. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
Mazur, P. K., Herner, A., Mello, S. S., Wirth, M., Hausmann, S., Sánchez-Rivera, F. J., Lofgren, S. M., Kuschma, T., Hahn, S. A., Vangala, D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3952 · Cited by 397
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408
NAD+ metabolism governs the proinflammatory senescence-associated secretome
Nacarelli, T., Lau, L., Fukumoto, T., Zundell, J., Fatkhutdinov, N., Wu, S., Aird, K. M., Iwasaki, O., Kossenkov, A. V., Schultz, D., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0287-4 · Cited by 402
Self-citationTh17 Cells in Cancer: The Ultimate Identity Crisis
Bailey, S. R., Nelson, M. H., Himes, R. A., Li, Z., Mehrotra, S., & Paulos, C. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00276 · Cited by 334
“Th17 CELL-MEDIATED INFLAMMATION IN CANCER Inflammation has long been recognized as a mediator of tumor progression in diseases such as colorectal (80), pancreatic (81, 82), and lung (83) cancer.”
Background
Metadata
- Authors
- Rielland, M., Cantor, D. J., Graveline, R., Hajdu, C., Mara, L., de Diego Diaz, B., Miller, G., & David, G.
- Affiliations
- New York University (US)
- Corresponding author
- David, Gregory
- Venue
- Journal of Clinical Investigation
- Published
- 2014-04-01
- Volume
- 124
- Issue
- 5
- Pages
- 2125-2135
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4001548
- OpenAlex
- W2012774586
- Cited by
- 76
- References
- 57
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 9 · 2019: 10 · 2018: 4 · 2017: 10 · 2016: 9 · 2015: 4 · 2014: 6
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- Samuel Waxman Cancer Research Foundation
- NYU Langone Medical Center
- Irma T. Hirschl Trust
- York University
- National Institutes of Health
- School of Medicine, New York University
- National Cancer Institute (T32CA009161, R21CA155736, R01CA148639, P30CA016087)
- National Institute of General Medical Sciences (T32GM007308)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- SIN3B, pancreatic ductal adenocarcinoma, oncogene-induced senescence, KRAS, inflammation, IL-1α, histone deacetylase, tumor progression, pancreatitis, therapeutic target
- MeSH terms
- Animals, Humans, Inflammation, Pancreatic Neoplasms, Proto-Oncogene Proteins, Repressor Proteins, Proto-Oncogene Proteins p21(ras), Cellular Senescence, Mice, Knockout, ras Proteins, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Mice, Interleukin-1alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.